CHEMBIO DIAGNOSTICS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-06-27: Reporting owner Teso-Lichtman Leslie; Form 4; Security Nonqualified stock options; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-05-24: Reporting owner Teso-Lichtman Leslie; Form 4; Security Nonqualified stock options; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-04-27: Reporting owner Angelico Paul; Form 3; Security Incentive stock options; Transaction Holding.
- 2022-04-27: Reporting owner Angelico Paul; Form 3; Security Incentive stock options; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-06-27 | Teso-Lichtman Leslie Director | 4 | Nonqualified stock options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +82,286 82,286 owned after | $1.25 exercise price | 2022-06-29 | |
| 2022-05-24 | Teso-Lichtman Leslie Director | 4 | Nonqualified stock options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,143 41,143 owned after | $1.25 exercise price | 2022-05-26 | |
| 2022-04-27 holding as of filing | Angelico Paul Officer (See remarks) | 3 | Incentive stock options Derivative · Direct | Holding | $5.61 exercise price | 2022-04-27 | ||
| 2022-04-27 holding as of filing | Angelico Paul Officer (See remarks) | 3 | Incentive stock options Derivative · Direct | Holding | $4.65 exercise price | 2022-04-27 | ||
| 2022-04-27 holding as of filing | Caso Charles Officer (See remarks) | 3 | Incentive stock options Derivative · Direct | Holding | $4.65 exercise price | 2022-04-27 | ||
| 2022-03-11 | Potthoff John Gary Director | 4 | Nonqualified stock options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,143 41,143 owned after | $1.25 exercise price | 2022-03-15 | |
| 2022-03-11 | Davis Katherine Lyon Director | 4 | Nonqualified stock options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,143 41,143 owned after | $1.25 exercise price | 2022-03-15 | |
| 2022-03-11 | Acheson David Director | 4 | Nonqualified stock options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,143 41,143 owned after | $1.25 exercise price | 2022-03-15 | |
| 2022-03-11 | Bespalko David William Director | 4 | Nonqualified stock options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,143 41,143 owned after | $1.25 exercise price | 2022-03-15 | |
| 2022-01-05 | Steenvoorden Lawrence J. Officer (See remarks) | 4 | Nonqualified stock options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $1.12 exercise price | 2022-01-06 |